| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 4 | +23.6K | 48.6% | $2.67 | +$62.9K |
| Sells | 1 | -25K | 51.4% | $3.06 | -$76.5K |
| Net | +3 | -1.4K | -2.9% | -$13.6K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| James C. Czirr | 10%+ Owner | $22.7M | -$76.5K | -0.34% | Apr 22, 2024 |
| Richard E. Uihlein | Director, 10%+ Owner | $17.7M | Jan 24, 2024 | ||
| 10X Fund, L.P. | 10%+ Owner | $10.6M | Dec 31, 2022 | ||
| Joel Lewis | President and CEO, Director | $3.15M | +$3.39K | +0.11% | Apr 24, 2024 |
| Kevin D. Freeman | Director | $351K | +$43.8K | +14.3% | Oct 17, 2024 |
| Kary Eldred | Director | $142K | +$4.11K | +2.98% | Oct 23, 2024 |
| Richard A. Zordani Jr. | Director | $78.4K | +$11.6K | +17.3% | Aug 22, 2024 |
| Pol F. Boudes | Chief Medical Officer | $71.4K | Jan 24, 2024 | ||
| Jack W. Callicutt | Chief Financial Officer | $71.4K | Jan 24, 2024 | ||
| Khurram Jamil | Chief Medical Officer | $23.9K | Aug 2, 2024 | ||
| Benjamin Sr Carson | Director | Jan 24, 2024 | |||
| Gilbert F. Amelio | Director | Jan 24, 2024 | |||
| Harold H. Shlevin | Director | Jan 26, 2023 | |||
| Gilbert S. Omenn | Director | Jan 24, 2024 | |||
| Elissa J. Schwartz | Director | Jan 24, 2024 | |||
| Marc Rubin | Director | Jan 24, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|